You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bgb-11417

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory Trial

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • +2 more
  • BGB-11417
  • (no location specified)
Jul 18, 2023

Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma (MCL), Relapsed Mantle Cell Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • BGB-11417
  • (no location specified)
Jul 25, 2022

Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Leukemia
  • +4 more
  • BGB-11417
  • (no location specified)
Jul 27, 2022

Acute Myeloid Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumor Trial in Worldwide (BGB-11417, Azacitidine, Posaconazole)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • BGB-11417
  • +2 more
  • Houston, Texas
  • +23 more
Aug 18, 2022

Mature B-cell Malignancies Trial in Suzhou (BGB-11417)

Recruiting
  • Mature B-cell Malignancies
  • BGB-11417
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Suzhou University
Aug 4, 2021

Relapsed/Refractory Multiple Myeloma Trial in Worldwide (BGB-11417, Dexamethasone, Carfilzomib)

Recruiting
  • Relapsed/Refractory Multiple Myeloma
  • BGB-11417
  • +2 more
  • Birmingham, Alabama
  • +21 more
Aug 8, 2022

Mature B-Cell Malignancies Trial in Worldwide (BGB-11417, Zanubrutinib)

Recruiting
  • Mature B-Cell Malignancies
  • Stanford, California
  • +26 more
Dec 16, 2021